Replies to post #13159 on Rebus Holdings Inc (RBSH)

[powerbattles]

GenSpera’s technology was developed over 15 years at Johns Hopkins and other global research centers and funded by over $15 million in grants from the U.S. National Institutes of Health, the National Cancer Institute, and the U.S. Department of Defense, among others.

From 8-k

http://www.getfilings.com/sec-filings/100712/GENSPERA-INC_8-K/v190398_ex99-01.htm